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ABSTRACT
Intestinal smoothmuscle cells (iSMCs) are a crucial component of the
adult gastrointestinal tract and support intestinal differentiation,
peristalsis and epithelial homeostasis during development. Despite
these crucial roles, the origin of iSMCs and the mechanisms
responsible for their differentiation and function remain largely
unknown in vertebrates. Here, we demonstrate that iSMCs arise
from the lateral plate mesoderm (LPM) in a stepwise process.
Combining pharmacological and genetic approaches, we show that
TGFβ/Alk5 signaling drives the LPM ventral migration and
commitment to an iSMC fate. The Alk5-dependent induction of
zeb1a and foxo1a is required for this morphogenetic process: zeb1a
is responsible for driving LPM migration around the gut, whereas
foxo1a regulates LPM predisposition to iSMC differentiation. We
further show that TGFβ, zeb1a and foxo1a are tightly linked together
by miR-145. In iSMC-committed cells, TGFβ induces the expression
of miR-145, which in turn is able to downregulate zeb1a and foxo1a.
The absence of miR-145 results in only a slight reduction in the
number of iSMCs, which still express mesenchymal genes but fail to
contract. Together, our data uncover a cascade of molecular events
that govern distinct morphogenetic steps during the emergence and
differentiation of vertebrate iSMCs.
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INTRODUCTION
Smooth muscle cells (SMCs) constitute a vital proportion of various
organs, including those of the gastrointestinal (GI) tract, urogenital
tract, respiratory tract and vascular system. Despite their crucial
contribution to organ function, little is known about the ontogeny
and genetic developmental programs that drive SMC differentiation
in vertebrates. A key challenge to studying the mechanisms of SMC
development and differentiation arises from the complex origin of
SMCs from seemingly multiple and sometime unknown cell types
(Kumar and Owens, 2003). Current concepts describe most SMCs
as arising from the condensation of surrounding, vaguely defined
mesenchyme under the control of local environmental cues. In
coordination with the different cell types present in the developing
organs, mesenchyme initially forms early-synthetic SMCs that later
develop into mature contractile SMCs (Gabella, 2002). A complex
SMC lineage is the intestinal SMCs (iSMCs), which is found around
the enteric endoderm-derived epithelium. iSMCs are indispensable
for proper gut organogenesis as they contribute to vilification and
provide the contractility necessary for intestine functionality (Shyer
et al., 2013). Defects in their development are apparent in human
congenital disorders such as visceral myopathy.
Lateral plate mesoderm (LPM) is a highly dynamic mesoderm
field composed of bilateral stripes of cells appearing in post-gastrula
embryos. The LPM is patterned early into distinct regions that will
give rise to precursors of kidney, heart, endothelium, hematopoietic
and limb cell fates (Davidson and Zon, 2004; Gering et al., 2003;
Mosimann et al., 2015). Although previous work has suggested that
iSMCs arise from the lateral plate mesoderm (LPM), genetic
demonstration for this origin is still missing in a vertebrate model
(Roberts et al., 1998). Currently lacking is a cellular and molecular
concept of how the bilateral precursor stripes form the smooth
muscle layer surrounding the endoderm-derived gut tube, and
whether these cells indeed derive from the LPM. How the possibly
LPM-derived iSMC precursors induce and regulate their migration
to converge on and surround the gut tube also remains unknown. In
the past, early events of LPM and gut morphogenesis have been well
described, taking advantage of the zebrafish model system (Horne-
Badovinac et al., 2003; Stainier, 2005). The anatomical
conservation and relative simplicity of its intestine have made the
zebrafish an ideal vertebrate model for studying early gut
development and endodermal differentiation (Bagnat et al., 2007;
Horne-Badovinac et al., 2003; Wallace et al., 2005; Yin et al.,
2010), and the initial characterization of iSMCs (Georgijevic et al.,
2007; Wallace et al., 2005; Whitesell et al., 2014).
Organogenesis requires a highly coordinated series of molecular
and cellular events. Among the different categories of molecules
involved in organ formation and cell fate control, miRNAs represent
a sophisticated level of gene regulation that coordinates a broad
spectrum of biological processes, from development to cancer
(Kloosterman and Plasterk, 2006). miRNAs are endogenous ∼22-
nucleotide RNAs that control protein expression through
translational repression of mRNAs. In cooperation with
transcription factors, miRNAs can establish autoregulatory
feedback loops and feed-forward loops, reaching high levels of
complexity in the regulation of gene expression and subsequently of
biological processes (Tsang et al., 2007).
Here, combining genetic, pharmacological and bioinformatics
approaches, we characterize cellular and molecular events occurring
during LPM differentiation and intestinal SMC development in
zebrafish. Using genetic lineage tracing, we demonstrate that iSMCs
arise from the LPM in a stepwise process. We show that a TGFβ-
and Zeb1a-mediated migration of hand2-positive LPM cells around
the gut endoderm drives commitment of epithelial LPM into
mesenchymal iSMC progenitors. TGFβ/Alk5 signaling also leads to
the expression of miR-145 that is required to switch off theReceived 8 December 2015; Accepted 9 December 2016
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migrating signature of the LPM and to downregulate translation of
the Forkhead transcription factor gene foxo1a, a novel component of
LPM and iSMC differentiation. Together, our data uncover a
sequence of unique molecular events that govern distinct steps
during the emergence and differentiation of iSMCs from migrating
LPM in vertebrates. Understanding of how iSMCs develop is key to
targeting smooth muscle cell-related pathologies and to improve
prognostic and therapeutic approaches.
RESULTS
Lateral plate mesoderm gives rise to intestinal SMCs
Previous reports indicated that zebrafish embryos mutant for the
LPM-expressed transcription factor gene hand2 (heart and neural
crest derivatives expressed 2) (Yelon et al., 2000) completely lack
iSMCs (Santoro et al., 2009). To investigate how LPM emergence
and differentiation are related to iSMC formation, we combined
different approaches.
We first tracked LPM derivatives in a BAC-based reporter
transgenic line Tg(hand2:EGFP)pd24 based on the endogenous
hand2 cis-regulatory elements that also express in the presumptive
posterior LPM from early somitogenesis onwards [Tg(hand2:
EGFP)pd24] (Yin et al., 2010). Using confocal microscopy of
transverse embryo cross-sections, we examined EGFP expression
between somites 7 and 13, a region in which the enteric endoderm is
located at the midline (i.e. above the yolk extension; Fig. 1A and
Fig. S1A). By 24 h post-fertilization (hpf ), hand2-expressing cells
in zebrafish embryos form bilateral mesodermal sheets spanning the
entire anterior-posterior (A-P) extent of the trunk. At this time point,
this remaining undifferentiated LPM is located lateral to the gut and
is composed of polarized proliferating epithelial cells (Horne-
Badovinac et al., 2003; Yin et al., 2010). By 30 hpf, these hand2-
expressing epithelial sheets started to cover the dorsal region of the
gut endoderm. By 36 hpf, the LPM had enfolded the region
underneath the endoderm through a process reminiscent of
mesenchymalization. By 48 hpf, the gut tube was completely
surrounded by hand2-expressing cells. From 60 hpf onwards, these
hand2-positive cells expressed acta2 (α-smooth muscle actin) and
tagln (transgelin or sm22a-b). These genes are the earliest known
markers of committed smooth muscle progenitor cells in vertebrates
and remain expressed in differentiated SMCs (Georgijevic et al.,
2007; Solway et al., 1995; Santoro et al., 2009). By 96 hpf, iSMCs
were fully differentiated in contractile longitudinal and circular
smooth muscle fibers, and promoted peristaltic movement of the gut
in preparation for the onset of exogenous feeding (Wallace et al.,
2005).
To further characterize the morphogenesis of the hand2-
expressing LPM, we tested expression of epithelial markers, such
as aPKC (atypical protein kinase C), and markers of
mesenchymalization, such as N-cadherin, in the LPM from 24 hpf
onwards (Fig. 1B,C). These results revealed that hand2-expressing
bilateral LPM cells express both markers of epithelial and
mesenchymal cells as early as 24 hpf. Our data support the
possibility that the LPM cells acquire the feature of a collective
migrating epithelial mesenchyme, a common event during
embryonic developmental and tissue repair (Rørth, 2012).
By 72 hpf, a subpopulation of hand2-expressing LPM cells start
to express the SMC marker Tagln. As shown in Fig. 1C, all the
Tagln-positive cells are also positive for hand2 expression,
supporting the conclusion that all the iSMCs originate from LPM/
hand2+ cells (Fig. 1D). Tg(hand2:EGFP)pd24 also exhibited EGFP-
positive cells located in the enteric submucosa that were negative for
Tagln but positive for Hu, a marker specific for neurons (Fig. S1B).
As hand2 is also expressed in neural crest derivatives and is required
for the development of neural crest-derived neurons (Olden et al.,
2008; Reichenbach et al., 2008), we concluded these cells are
enteric neurons. Taken together, our observations confirm and
extend previous reports that hand2-expressing bilateral LPM cells
give rise to the iSMC layer surrounding the developing gut tube.
As a second and independent approach to link iSMCs to an LPM
origin, we performed Cre/lox-mediated lineage tracing in the
Tg(drl:creERT2) line, which uniquely expresses tamoxifen-
inducible Cre recombinase in all presumptive LPM precursors
already during late epiboly (Mosimann et al., 2015).We crossed drl:
creERT2 with the ubiquitous GFP-to-mCherry loxP lineage trace
transgene ubi:Switch (Mosimann and Zon, 2011) and induced Cre
activity at late epiboly/tailbud stages, when drl transgene expression
is confined to presumptive LPM cells. We detected lineage-labeled
precursor iSMCs at 72 hpf and iSMCs around the gut along the
entire length of the trunk, concomitant with the expected LPM-
derived lineage labeling of the pronephric duct and endothelial cells
(Fig. 2A). Lineage-labeled cells surrounding the gut co-stained with
the iSMC marker Tagln as early as 72 hpf (Fig. 2B and Fig. S2B).
We found lineage-labeled iSMCs in all embryos treated with 4-OH
at 1 ss (n=31) (Fig. 2C). In all embryos tested, we observed different
grades of switching efficiency, ranging from a few iSMC labeled
(class I) cells to complete lineage labeling of all gut-surrounding
iSMCs (class III). The variability and efficiency corresponds to the
ubiquitous ubi:Switch recombination capacity in controls (Fig. S2A)
and in our previous ubi:Switch characterizations (Felker et al., 2016).
Taken together, our genetic lineage tracing results demonstrate that
initially drl-expressing and subsequently hand2-expressing LPM cells
form mesenchymal cells that later on become iSMCs. Altogether, our
data show that the LPM gives rise to iSMCs in zebrafish and support
the notion that the signaling and genetic pathways driving the
emergence and differentiation of the LPM might also underlie iSMC
formation.
LPM requires TGFβ signaling to differentiate into iSMCs
To specifically track the development and maturation of iSMCs, we
next derived two independent transgenic zebrafish reporter lines
with fluorescent markers under the control of the acta2 and tagln
minimal cis-regulatory elements (Fig. S3A,B; see Materials and
Methods for details). Although reporter expression in these lines
differed in intensity and specificity, both Tg(acta2:mCherry)uto5
and Tg(tagln:CAAX-EGFP)uto37 embryos exhibit fluorescent
marker expression in immature iSMCs beginning at 60-72 hpf. By
96 hpf and through adulthood, both reporter lines mark mature and
contractile iSMCs covering the entire intestine and swim bladder
(Fig. S3A,B). Our new acta2 and tagln transgenic reporters are
therefore bona fide reporter lines for immature and mature iSMCs.
We next used our acta2 and tagln reporter lines as readouts to
screen for signaling pathways that drive iSMC formation using a
panel of established chemical inhibitors (Table S2). Chemical
inhibition from 20 hpf of the TGFβ type I receptors by SB431542
and LY364947 selectively impaired iSMC development (Fig. 3A,B
and data not shown). We further confirmed the role of TGFβ in
iSMCs by analyzing ltbp3morphants that were previously shown to
specifically phenocopy Alk5 inhibition (Zhou et al., 2011). Both
pharmacological and genetic perturbation of TGFβ signaling
disrupted iSMC differentiation in vivo without interfering with
overall gut endoderm specification and morphology (Fig. 3A,B and
Fig. S3C). To confirm these data, we then evaluated iSMCs
differentiation markers in Tg(hsp70:caALK5), in which heat shock
triggers constitutive Alk5 activity and signaling (Zhou et al., 2011).
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Heat-shock-induced expression of constitutively active Alk5
increased acta2, tagln and myh11 expression, further supporting
the role of TGFβ signaling in promoting iSMCmainly through Alk5
receptor (Fig. S3D).
One of the key functions of TGFβ signaling during
development is to promote cell migration and invasion (Lim
and Thiery, 2012; Zhang et al., 2014). We consequently
hypothesized that TGFβ could also control the migration of
Fig. 1. LPM gives rise to iSMCs in zebrafish embryos. (A) Time-course analyses of Tg(hand2:EGFP)pd24 and iSMC marker expression (Tagln) during
intestinal development. Tg(hand2:EGFP)pd24 embryos were fixed at different time points from 24 hpf until 96 hpf. Upper panel: confocal transverse sections of
the posterior gut region between the somites 7 and 13 of Tg(hand2:EGFP)pd24 embryos stained with phalloidin (gray) and Tagln (red) (single channels are
shown in Fig. S1A). The dashed yellow lines highlight LPM/hand2+ cells, whereas the dashed white lines highlight the enteric endoderm (g). Migration of the
LPM is indicated by arrows. Asterisks indicate single-cell nuclei. ISMC differentiation is visible during intestinal development by expression of Tagln; blue
indicates nuclei; g, gut. Scale bar: 30 μm. Bottom panel: schematic representation of LPM/hand2+ conversion to iSMCs in the gut region of developing
zebrafish embryos. Green, LPM; pink, endoderm; red, iSMCs; p, pronephros; s, somite; PCV, posterior cardinal vein; y, yolk. (B) Analyses of Tg(hand2:
EGFP)pd24 and polarity and mesenchymal markers during LPM development at 24 hpf. Confocal transverse sections of the posterior gut region between the
somites 7 and 13 of Tg(hand2:EGFP)pd24 embryos stained with aPKC or N-cadherin. Nuclei are in blue; g, gut. Scale bars: 30 μm. Asterisks indicate single-
cell nuclei while the dashed yellow lines highlight LPM/hand2+ cells. (C) Analyses of Tg(hand2:EGFP)pd24 and polarity and mesenchymal markers during LPM
development at 48 hpf. Confocal transverse sections of the posterior gut region between the somites 7 and 13 of Tg(hand2:EGFP)pd24 embryos stained with
aPKC (left, red) or N-cadherin (right, red). Blue indicates nuclei; g, gut. Scale bars: 30 μm. (D) Analyses of Tg(hand2:EGFP)pd24 and iSMC marker expression
(Tagln) at 72 hpf. Confocal transverse sections of the posterior gut region between the somites 7 and 13 of Tg(hand2:EGFP)pd24 embryos stained with Tagln
(red) show that all differentiated iSMC are also Tg(hand2:EGFP)pd24 positive. These observations suggest that posterior LPM expression of hand2 does not
demarcate the entire LPM, but rather is confined to the presumptive iSMC progenitors from its expression onset after LPM formation. Nuclei are in blue; g, gut.
Scale bars: 30 μm.
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Fig. 2. drl-positive LPM cells give rise to iSMC. (A) Schematic of the drl:creERT2×ubi:lox-EGFP-lox-mCherry (ubi:switch) crosses. Double-positive embryos
were induced at the one-somite stage with 4-OH tamoxifen (10 µM final concentration). This activates the Cre recombinase, which then excises the loxP-flanked
EGFP cassette and brings mCherry under control of the ubi promoter to lineage trace the switched cells. Photomicrographs of transverse vibratome sections of
posterior trunk region (dr:creERT2;ubi:Switch) are shown below. Sections were imaged with a Zeiss LSM710 40× objective. Scale bar: 50 µm. Higher
magnification of the intestinal region. The merged channel comprises EGFP, mCherry and DAPI. (B) Transverse vibratome sections of the posterior trunk region
(dr:creERT2;ubi:Switch). Higher magnifications of the intestinal region. iSMCs are stained using transgelin antibody to compare with lineage labeling by drl:
creERT2. Scale bar: 30 µm. The merged channel comprises EGFP, mCherry and DAPI. (C) Transverse vibratome sections of the posterior trunk region (drl:
creERT2xubi:switch). Highermagnification of the intestinal region showing the different switching efficacy for iSMCs after 4-OH treatment at the one-somite stage.
Class I, few iSMC are switched; class II, half iSMC are switched; class III, the entire population of iSMCs surrounding the gut are switched. The occurrences of the
switching efficacies are: class I, 28% (9/31); class II, 50% (15/31); class III, 22% (7/31). Asterisks indicate switched iSMCs. Sections were imaged with a Zeiss
LSM710 40× objective. Scale bar: 25 µm. The merged channel comprises EGFP, mCherry and DAPI.
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hand2-positive LPM. In accordance with this hypothesis, LPM
ventral migration was severely yet specifically impaired after
SB431542 treatment and ltbp3 knockdown (KD) at 48 hpf
(Fig. 3C), whereas the total number of LPM/hand2+ cells did not
change significantly in Tg(hand2:EGFP)pd24 embryos upon
TGFβ inhibition (Fig. 3D and Fig. S3E). These data support a
new role for TGFβ signaling in LPM-to-iSMC differentiation by
promoting initial LPM migration.
To elucidate the downstream targets of TGFβ that might drive
LPM migration and differentiation in iSMC, we analyzed
transcriptomic data to identify: (1) genes induced by TGFβ –
specifically and differentially expressed between human alveolar
basal epithelial cells (A549) after 72 h of TGFβ induction and
untreated cells (Sartor et al., 2010); (2) genes expressed in intestinal
mesenchyme – specifically and differentially expressed between the
mesenchymal and epithelial fraction of mouse intestine (Li et al.,
2007) (Fig. S3F). Among those resulting genes, we focused our
attention on zeb1a (zinc finger E-Box binding homeobox 1) and
foxo1a (forkhead box protein O1), two transcription factor-
encoding genes whose roles during the development of the GI
tract remain unknown.
Zeb1a is required for LMP mesenchymalization and for iSMC
differentiation
Zeb1a is a potent mediator of cell migration and invasion of
tissues downstream of TGFβ signaling (Lamouille et al., 2014;
Zhang et al., 2014). Accordingly, a specific role for Zeb1a during
vascular SMC differentiation has been well established (Nishimura
et al., 2006). However, a potential role for ZEB family members in
iSMC development has not yet been determined. Therefore, we
investigated whether ZEB1 is required for iSMC formation
in zebrafish development using our two reporter transgenic lines.
We silenced zeb1a in Tg(acta2:mCherry)uto5 and Tg(hand2:
EGFP)pd24 embryos; injections of two independent zeb1a
morpholinos (translation and splicing blocking) both abrogated
iSMC development without affecting gut or endoderm
development and morphology (Fig. 4A,B and Fig. S4A-C). To
understand whether this defect was due to impaired LPM
migration, we analyzed LPM morphology 48 hpf after silencing
zeb1a. In zeb1a-impaired embryos, the LPM does not complete its
migration and fails to cover the ventral region of the gut endoderm
(Fig. 4C). We did not observe any significant differences in hand2
expression levels compared with controls (Fig. S4D) nor in LPM/
Fig. 3. LPM migration is guided by TGFβ signaling.
(A) Pharmacological and genetic TGFβ signaling blockade
impairs iSMC differentiation. Fluorescent images of Tg(acta2:
mCherry)uto5 embryos treated with SB431542 (a TGFβ type I
receptors inhibitor) or ltbp3 knockdown (encoding a protein
that regulates the bioavailability of TGFβ ligands) exhibit no or
few iSMCs, as evaluated bymCherry and Tagln expression in
the gut region (g) (arrow) at 72 hpf. Scale bars: 200 μm. n,
notochord; h, heart. Insets show confocal transverse sections
of posterior gut regions (dashed vertical line) of SB431542-
treated embryos and embryos injected with ltbp3 morpholino
and stained for Tagln (green). The numbers of embryos
showing the phenotype are indicated. Blue indicates nuclei.
Scale bars in insets: 10 μm. (B) Alk5 blockade does not affect
endoderm development and differentiation. Box and whisker
plots show the percentage of iSMCs or endodermal cells
isolated by fluorescent-activated cell sorting (FACS)
experiments from the trunks spanning from somite 1 to 13 of
the double Tg(acta2:mCherry)uto5 (Xia.Eef1a1:GFP)s854
embryos at 72 hpf after chemical (SB431542) or genetic
(ltbp3 KD) Alk5 signaling blockade. The boxplots show the
maximum, minimum, upper and lower quartiles, and the
sample median. Asterisks represent the results of one-way
ANOVA-Dunnett’s post-hoc test (**P<0.01, ****P<0.0001;
from left to right: n=8, n=3, n=5, n=5, n=5 and n=5 groups of
10-20 embryos). (C) Blockade of TGFβ signaling impairs LPM
migration. Upper panel: confocal transverse sections of
Tg(hand2:EGFP)pd24 stained with phalloidin (red) and
Hoechst (blue) showing a reduced LPM migration at 48 hpf
(arrows) after TGFβ inhibition. Scale bars: 15 μm. The
number of embryos exhibiting this phenotype is indicated.
Lower panel: schematic representation of impaired LPM
migration (black arrows) observed with the lack of TGFβ
signaling in zebrafish embryos. Green, LPM; pink, endoderm.
(D) Alk5 blockade does not affect LPM. Box and whisker plots
show the percentage of LPM cells isolated by fluorescent-
activated cell sorting (FACS) experiments from the trunks of
Tg(hand2:EGFP)pd24 embryos at 48 hpf after chemical
(SB431542) or genetic (ltbp3 KD) Alk5 signaling inhibition.
The boxplots show the maximum, minimum, upper and lower
quartiles, and the sample median. From left to right: n=13,
n=18 and n=10 groups of 10-20 embryos.
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hand2+ cell number (Fig. S4E). We also collected hand2+ cells
from zeb1a knockdown embryos by FACS and analyzed a set of
genes associated with mesenchymal migration by qPCR.
Compared with controls, silencing of zeb1a markedly increased
the expression of epithelial markers, including cdh1 (E-cadherin)
and oclna (occludin A), in the hand2-positive cell population.
Such molecular features resemble the retention of the compact
tight epithelial structure, possibly explaining the migration defects
observed before (Fig. 4D).
Altogether, these data support a specific role for TGFβ signaling
and zeb1a in driving LPM migration around the gut, a key
step towards iSMC commitment. Once lateral-to-medial
hand2-positive LPM migration has occurred, mesenchymal
cells that now surround the endoderm start to differentiate into
iSMCs.
Foxo1a is required for LPM and iSMC differentiation
Among the potentially TGFβ-regulated target genes in the
intestinal mesenchyme and expressed in the LPM, we also
identified foxo1a. Foxo1 belongs to the Forkhead family of
transcription factors and regulates myogenic growth and
differentiation, maintenance of stemness, and metabolism
(Eijkelenboom and Burgering, 2013; Sanchez et al., 2014). A
role for foxo1a in iSMC development has not been described
previously. To investigate at which step of LPM-to-iSMC
differentiation foxo1a might act, we knocked down foxo1a in
Tg(acta2:mCherry)uto5 embryos with both a translational and
splice-blocking morpholinos. In addition, we used AS1842856, a
specific chemical inhibitor of Foxo1 activity (Nagashima et al.,
2010) (Fig. S5A,B). Although foxo1a knockdown did not affect
overall embryonic development (nor overall body morphology and
gut endoderm morphology or differentiation), it impaired iSMC
cell number and marker expression (Fig. S5A,C,D). We then
evaluated whether foxo1a was required in the LPM. We found that
both genetic and pharmacological inhibition of foxo1a reduced
LPM/hand2+ cell number (Fig. 5A,B and Fig. S5E) and LPM
proliferation (Fig. 5C). Nonetheless, foxo1a knockdown did not
alter LPM migration (Fig. 5A) or the expression of genes
associated with EMT and migration compared with controls
(Fig. S5F). These data indicate that, complementary to our
findings on zeb1a function, foxo1a is dispensable for LPM
migration but it is required for LPM proliferation and
maintenance.
To further understand the role of foxo1a in the LPM-to-iSMC
differentiation, we performed foxo1a overexpression analysis and
looked at the LPM differentiation state by measuring hand2
expression levels as an indicator of the LPM versus iSMC
differentiation state. Overexpression of foxo1a stimulated hand2
expression in the embryo (Fig. 5D,E), impaired SMC marker
expression and iSMC differentiation (Fig. 5D,F), and affected LPM
cell number or proliferation (Fig. 5D and data not shown). These
data propose foxo1a as a potent previously unrecognized molecular
regulator of LPM during early zebrafish iSMC development.
Altogether, our data reveal that Zeb1a and Foxo1a each control
distinct roles in differentiating hand2-positive LPM (migration
versus cell number/proliferation) towards forming functional
iSMCs.
Fig. 4. TGFβ-driven LPM morphogenesis requires zeb1a. (A) Knockdown
of the transcription factor zeb1a impairs iSMC differentiation. Fluorescent
images of Tg(acta2:mCherry)uto5 embryos at 72 hpf after zeb1a morpholino
injections. zeb1a knockdown embryos exhibit decreased mCherry and Tagln
expression in the gut region (g) compared with controls (arrow). Scale bars:
200 μm. Insets show confocal transverse sections of the posterior gut region
(dashed line) in embryos stained for Tagln (green). The number of embryos
exhibiting the phenotype is indicated. Nuclei are in blue. Scale bars in insets:
10 μm. n, notochord; h, heart. (B) Knockdown of zeb1a does not alter
endoderm morphology and differentiation. Box and whisker plots show the
percentage of iSMCs or endodermal cells isolated by fluorescent-activated cell
sorting (FACS) experiments from the trunk of double Tg(acta2:mCherry)uto5
(Xia.Eef1a1:GFP)s854 embryos at 72 hpf after zeb1a downregulation. Although
the number of iSMCs is severely reduced by zeb1a knockdown, endodermal
cells are normal. The boxplots show the maximum, minimum, upper and lower
quartiles, and the sample median. Asterisks represent the results of unpaired
t-tests of mean difference=0 (***P<0.001; n=6 groups of 10-20 embryos).
(C) Knockdown of zeb1a impairs LPM ventral migration. Upper panel: confocal
transverse sections of Tg(hand2:EGFP)pd24 stained with phalloidin (red). The
number of embryos exhibiting this phenotype is indicated. Scale bars: 15 μm.
Lower panel: schematic representation of impaired migration in zeb1a
knockdown embryos. (D) zeb1a differentially regulates expression of genes
associated with migrating phenotypes in LPM. Histograms show qPCR
analyses of defined genes in LPM cells sorted from Tg(hand2:EGFP)pd24 after
zeb1a knockdown and the relative controls at 48 hpf. Compared with controls,
the knockdown of zeb1a upregulates genes (such as E-cadherin and occludin
A) associated with non-migrating epithelial structures (*P<0.05).
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zeb1a and foxo1a are both regulated by the smooth muscle-
specificmiR-145
We next addressed the spatial and temporal expression of zeb1a and
foxo1a in zebrafish, in particular if they are selectively expressed in
LPM.We performedwhole-mount in situ hybridization for zeb1a and
foxo1a mRNA from 24 to 48 hpf stages (Fig. S6A,B). zeb1a is
expressed mainly in a region surrounding the gut, possibly
mesenchymal tissue. foxo1a expression is evident as early as 24 hpf
in a bilateral region similar to the LPM stripes and in the gut region.
Later on, foxo1a is also expressed in the endoderm as demonstrated by
qPCR on endodermal TgBAC(cldn15la-GFP)pd1034-sorted cells
(Alvers et al., 2014; data not shown).
We next sought to explain the loss-of-function as well as gain-of-
function phenotypes of these genes in LPM and iSMCs
differentiation. We addressed how the complementary functions
of zeb1a and foxo1a are temporally regulated and tuned, and
whether a microRNA-based mechanism could be involved. miR-
145 is one of the most enriched microRNAs in SMCs where it
contributes to the acquisition of the SMC fate and contractile state
(Albinsson and Swärd, 2013; Boettger et al., 2009; Cordes et al.,
2009; Elia et al., 2009; Xin et al., 2009). Previous work has found
that miR-145 expression is also regulated by TGFβ in vascular
SMCs in vitro (Long and Miano, 2011). Therefore, we analyzed the
expression of miR-145 in developing zebrafish embryos and
observed that its expression begins at the onset of iSMC
maturation (∼72 hpf) (Fig. 6A). miR-145 was also strongly
upregulated in Tg(hsp70:caALK5) embryos after heat shock,
whereas chemical or genetic blockade of TGFβ signaling reduced
miR-145 expression (Fig. 6B,C). These data indicate thatmir-145 is
also regulated by TGFβ signaling in iSMCs in vivo and are
consistent with a conserved role for TGFβ signaling in miR-145
regulation in both vascular and visceral SMCs (Long and Miano,
2011).
In zebrafish, miR-145 seems highly and selectively expressed in
intestinal SMCs (Wienholds et al., 2005; Zeng and Childs, 2012).
Previous studies have shown that alterations in miR-145 expression
affect overall intestinal maturation (Zeng et al., 2009). To study the
role of miR-145 in iSMCs in more detail, we injected low doses of a
miR-145 dicer-blocking morpholino, sufficient to significantly
reduce mature miR-145 levels without altering endoderm
differentiation and overall embryo morphology (Fig. S7A-C).
Such miR-145 KD embryos displayed fewer iSMCs in uneven
Fig. 5. Foxo1a is required for LPM commitment to
iSMC differentiation. (A) foxo1a knockdown reduces
the number of LPM cells without affecting migration.
Confocal transverse sections of the gut (g) in Tg(hand2:
EGFP)pd24 embryos injected with foxo1a morpholino
and stained for phalloidin (red) at 48 hpf. The number of
embryos showing fewer LPM cells is indicated. Nuclei
are in blue. Scale bars: 15 μm. (B) Pharmacological and
genetic foxo1a inhibition affect LPM. Box and whisker
plots show the percentage of LPM cells isolated by
fluorescent-activated cell sorting (FACS) experiments
from trunks of Tg(hand2:EGFP)pd24 embryos 48 hpf
after chemical (AS1842856) or genetic (foxo1a
knockdown) foxo1a blockage. The boxplots show the
maximum, minimum, upper and lower quartiles, and the
sample median. Asterisks represent the results of one-
way ANOVA-Dunnett’s post-hoc test (***P<0.001,
****P<0.001; from left to right: n=12, n=6 and n=9 groups
of 10-20 embryos). (C) foxo1a knockdown impaired LPM
proliferation. The histogram shows the normalized count
of pH3-positive cells in the LPM of
Tg(hand2:EGFP)pd24 embryos at 48 hpf after foxo1a
knockdown or overexpression (*P<0.05). (D) foxo1a
mRNA overexpression blocks iSMC differentiation.
Confocal transverse sections of Tg(hand2:EGFP)pd24
embryos at 72 hpf overexpressing foxo1a mRNA and
stained for Tagln (red). The number of embryos
exhibiting the phenotype is indicated. Nuclei are in blue.
Scale bars: 15 μm. (E) foxo1a mRNA overexpression
increases hand2 expression. Histograms show hand2
mRNA levels measured by qRT-PCR in foxo1a-
overexpressing embryos compared with controls at
48 hpf (*P<0.05). (F) foxo1a mRNA overexpression
affect iSMC marker expression. Histograms show acta2,
tagln,myh11 and foxa3mRNA levels measured by qRT-
PCR in foxo1a-overexpressing embryos compared with
controls at 72 hpf. The expression of endodermal marker
foxa3 is not altered (**P<0.01, ***P<0.001).
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layers around the gut (Fig. 6D). These embryos exhibited only a
slight reduction in iSMC marker expression (Fig. S7D) and iSMC
number (Fig. 5F). iSMCs in miR-145-impaired embryos showed an
altered morphology that was typical of undifferentiated and
synthetic SMCs being less stretched and more rounded compared
with controls (Fig. 6E) (McHugh, 1996). Crucially, miR-145
knockdown embryos showed severe contractility defects in iSMCs,
including deficiencies in swim bladder inflation and gut peristalsis
(Fig. S7C and Fig. 6G).
Since miRNAs function by binding and degrading target mRNAs
(Bartel, 2009) and by regulating their translation, we sought to
identify which protein-coding genes are targets of miR-145 during
iSMCs development. We filtered our list of 487 genes induced by
TGFβ and expressed in the embryonic intestinal mesenchyme
(Fig. S3F) for the presence of amiR-145 binding site. We obtained a
list of 41 putative miR-145 targets conserved in human and mouse,
containing several genes that had previously been confirmed to be
miR-145 targets (Table S3). Among them we found foxo1a, also
predicted to be a target in zebrafish. Another gene was zeb2, which
has recently been shown to be a direct target of miR-145 (Ren et al.,
2014). Within the ZEB gene family in zebrafish, zeb1a has a
predicted miR-145 target site. Combined, our data reveal that our
identified iSMC regulators foxo1a and zeb1a are potential targets of
the SMC-controlling microRNA miR-145.
To test whether zeb1a and foxo1a transcripts are physiologically
relevant targets of miR-145 during zebrafish SMC differentiation,
we used complementary approaches. We first probed the ability of
zebrafish miR-145 to directly bind zeb1a and foxo1a 3′ UTR by
luciferase experiments. To achieve this, we cloned the 3′ UTR of
both genes into a luciferase reporter vector and performed reporter
assays in HEK-293 cells expressing a zebrafish miR-145mimic or a
scramble mimic as negative control. Luciferase expression from the
reporter with the wild-type 3′ UTR of zeb1a was significantly
repressed but was rescued after mutation of miR-145 binding sites
(Fig. 6H and Fig. S7E). We obtained analogous results with the
3′ UTR of the foxo1a gene (Fig. 6H and Fig. S7E). Next, given the
Fig. 6. See next page for legend.
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unavailability of antibodies to measure Zeb1a and Foxo1a protein
levels, we measured the relative abundance of endogenous zeb1a
and foxo1a transcripts in control and experimentally manipulated
embryos by quantitative PCR (Fig. 6I). Injection of miR-145
morpholino resulted in a ∼2-fold increase in zeb1a and foxo1a
expression levels. These data demonstrate that endogenous zeb1a
and foxo1a transcript levels change in response to decreased miR-
145 activity. Finally, to address the consequence of miR-145-
dependent downregulation of zeb1a or foxo1a during iSMC
differentiation, we specifically blocked the miR-145-mediated
downregulation of zeb1a and foxo1a in live embryos using target
protector technology (Staton, 2011). Injections of zeb1a or foxo1a
target protectors (zeb1a-TP or foxo1a-TP) in zebrafish embryos
specifically impaired iSMC differentiation. foxo1a-TP injection
reduced the number of iSMCs (Fig. 6J) whereas zeb1a-TP
injection affected iSMC contractility (Fig. 6K). Strikingly, co-
injection of foxo1a-TP and zeb1a-TP phenocopied miR-145
knockdown embryos, including fewer hand2-positive iSMCs with
disorganized layer architecture (Fig. S7F), indicating that miR-145-
mediated targeting of zeb1a and foxo1amRNA are both required to
complete iSMC differentiation and maturation.
We hypothesized that miR-145 is required for differentiation of
iSMCs after migration and to allow immature iSMCs to become
peristaltic/mature iSMCs. We measured the mesenchymal state of
iSMCs in miR-145 knockdown embryos by analyzing the ratio of
cdh1 versus cdh2 (N-cadherin) expression. iSMCs with miR-145
knockdown exhibited severe downregulation of cdh1 and,
concomitantly, significant upregulation of cdh2 (Fig. 6L,M).
Using luciferase assays, we next determined that miR-145
negatively regulated other target genes known to mediate
migration, including podxl, fscn1a (fascin actin-bundling protein
1A) and fli1a (Feng et al., 2014; Larsson et al., 2009; Lin et al.,
2014) (Fig. 5N). Interestingly, we found that alk5b was also a bona
fide target of miR-145 (Fig. 6N), suggesting the existence of a
negative-feedback loop between miR-145 and the TGFβ pathway
that is responsible for miR-145 induction.
Altogether, these data suggest that miR-145 is required for iSMC
maturation and for the acquisition of contractile properties
downstream of initial iSMC fate commitment and LPM
mesenchymalization and migration. In addition, our results propose
that TGFβ-zeb1a and foxo1a regulate LPM morphogenesis and the
initial step of LPM-to-iSMC differentiation. ThemiR-145 expression
driven by TGFβ signaling is then required in immature hand2-
positive iSMCs to: (1) switch off themesenchymal program governed
by Foxo1a and the migration programs controlled by Zeb1a; and (2)
to promote maturation of iSMCs into contractile and fully
differentiated SMCs.
DISCUSSION
Despite their biological and clinical importance, the origin and
differentiation of gastrointestinal SMC have been scarcely
investigated to date, in particular compared with studies of
vascular SMC or endoderm development. Here, using the
zebrafish model system, we have studied the developmental origin
of vertebrate iSMCs and have identified a genetic program
responsible for iSMC differentiation and maturation.
Our data provide evidence that identifies the LPM as the lineage
that gives rise to SMCs in the GI tract of zebrafish embryos by
combining reporter transgene imaging and genetic lineage-tracing
experiments using the LPM-expressed drl:creERT2 (Mosimann
et al., 2015). Our lineage-tracing results provide the first genetic
confirmation in vertebrate that smooth muscle cells in the gut region
are derived from lateral mesodermal organ precursors. These
findings are consistent with and extend previous cell culture and
transplantation experiments performed in Xenopus and chick,
Fig. 6. Zeb1a and Foxo1a are regulated by the TGFβ-dependent miR-145
expression. (A) miR-145 expression occurs from 72 hpf onwards in zebrafish
embryos. Time-course analysis of miR-145 expression in whole zebrafish
embryos. qPCR was performed on total RNA extracted from embryos at the
indicated developmental stages. Values are normalized to miR-145 levels in
unfertilized eggs. (B) Alk5 activation promotes miR-145 transcription and
maturation. Histograms show the levels of mature miR-145 after activation of
Alk5 signaling using the inducible Tg(hsp70:caALK5) line, as assessed by qRT-
PCR analyses. (C) Blockade of Alk5 signaling significantly reducedmaturemiR-
145 levels. Histograms show the levels ofmaturemiR-145 after pharmacological
(SB431542) and genetic (ltbp3 knockdown) inactivation of Alk5 signaling
compared with controls, as assessed by qRT-PCR. (D) miR-145 knockdown in
zebrafish embryos impairs iSMC maturation. Confocal transverse sections of
miR-145 knockdown embryos stained for Tagln (green). Knockdown ofmiR-145
alters iSMC maturation as displayed by irregular morphology and shape of
iSMCs compared with controls (arrow). The number of embryos exhibiting this
phenotype is indicated. Nuclei are in blue. Scale bars: 15 μm. (E) miR-145
knockdown alters iSMC organization in the intestine. Confocal maximum
projection of iSMCs covering the gut after staining for Tagln (green) and cortical
actin (red). miR-145 knockdown embryos showed abnormal endoderm
coverage and iSMC morphology (arrows) compared with controls. The number
of embryos exhibiting this phenotype is indicated. Scale bars: 25 μm. (F) miR-
145 knockdown reduces iSMC number without affecting endoderm
differentiation. Box and whisker plots show the percentage of iSMCs and
endodermal cells isolated by fluorescent-activated cell sorting (FACS)
experiments from the trunks of double Tg(acta2:mcherry)uto5 (Xia.Eef1a1:
GFP)s854 embryos at 96 hpf after miR-145 knockdown. The boxplots show the
maximum, minimum, upper and lower quartiles, and the sample median.
Asterisks represent the results of unpaired t-tests of mean difference=0
(*P<0.05; from left to right: n=10, n=10, n=5 and n=5 groups of 10-20 embryos).
(G) Loss of miR-145 impairs gut peristalsis in zebrafish embryos. Histograms
show the percentage of embryos with peristaltic gut movement at 96 hpf after
miR-145 knockdown. (H) Zebrafish zeb1a and foxo1amRNA are directly bound
by miR-145. The histogram shows luciferase activity in mammalian cells co-
transfected with reporter constructs containing wild-type or mutant (mut) zeb1a
and foxo1a 3′ UTR, together with a miR-145 mimic or a scramble mimic. The
results are shown as the mean±s.d. of Firefly luciferase activity relative to the
controls, normalized with respect to Renilla luciferase activity. Asterisks
represent the results of one-way ANOVA-Dunnett’s post-hoc test (**P<0.01,
***P<0.001). (I) miR-145 knockdown increases foxo1a and zeb1a levels as
evaluated by qPCR on the trunk region of embryos at 96 hpf (*P<0.05,
**P<0.01). (J) The block of miR-145 and foxo1a binding in vivo reduces iSMC
number without affecting endoderm differentiation. Box and whisker plots show
the percentage of iSMCs or endodermal cells isolated by fluorescent-activated
cell sorting (FACS) experiments from the trunk of the double Tg(acta2:
mCherry)uto5 (Xia.Eef1a1:GFP)s854 embryos at 96 hpf after foxo1a target
protector (TPs) injection. The boxplots show themaximum,minimum, upper and
lower quartiles, and the sample median. Asterisks represent the results of
unpaired t-tests of mean difference=0 (*P<0.05; from left to right: n=7, n=7, n=3
and n=3 groups of 10-20 embryos). (K) Block ofmiR-145-zeb1a binding in vivo
affects gut peristalsis in zebrafish embryos. Histograms show the percentage of
embryos with peristaltic gut movement at 96 hpf after zeb1a TP injections.
(L,M) miR-145 knockdown upregulates the mesenchymal program in iSMCs.
Histograms show E-cadherin (L) and N-cadherin (M) mRNA levels evaluated by
qRT-PCR in iSMCs sorted from Tg(acta2:mCherry)uto5 embryos after miR-145
knockdown compared with control levels at 72 and 96 hpf.miR-145 knockdown
severely reduced E-cadherin mRNA levels but promoted N-cadherin mRNA
expression. These data suggest that miR-145 is required to switch off the
mesenchymalization program in iSMCs responsible for their appearance
(**P<0.01). (N) miR-145 directly targets Alk5 and several genes required for
pEMT. Histograms show relative luciferase activity in cells co-transfected with
reporter constructs containing the 3′ UTR of alk5, podxl, fascin1a, fli1a and
gata6 togetherwith amiR-145mimicor a scramblemimic. The results are shown
as the mean±s.d. of Firefly luciferase activity relative to controls, normalized to
Renilla luciferase activity. The data indicate that miR-145 targets the Alk5
receptor, as well as other mesenchymal genes, such as podxl, fascin and fli1a
(*P<0.05, **P<0.01). gata6, a known miR-145 target, was used as a control.
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respectively, that provided the first indications that the LPM gives
rise to iSMCs (Chalmers and Slack, 2000; Roberts et al., 1998).
iSMC formation happens notably later than the medial migration
and differentiation of other LPM-derived lineages, including the
bilateral precursors for cardiovascular, hematopoietic and renal cell
fates that functionally remodel prior to 24 hpf in zebrafish. The
absence of obvious defects in the other LPM-derived lineages after
TGFβ/zeb1a and foxo1a modulations suggests that these genes are
active only in the iSMC-fated LPM population, or that
compensatory mechanisms exist in other lineages. Curiously, the
sole posterior phenotype of hand2mutations in zebrafish is the lack
of iSMCs, suggesting a dedicated role for hand2 in the posterior
LPM stripe that is fated to form intestinal smooth muscle.
We identified TGFβ as a crucial regulator of LPM-to-iSMC
differentiation that sustains LPM ventral migration around the
endoderm. The TGFβ superfamily consists of several different
protein families, including TGFβ proteins, bone morphogenetic
proteins (BMPs), activins, Nodal and many others. Our data suggest
that a key role in LPM-to-iSMC differentiation is played by the
TGFβ type I receptor Alk5, which is targeted by both the inhibitors
we used in this study (SB431542 and LY364947). In addition,
previous work has also shown that ltbp3 inhibition phenocopies the
effect of LY364947 treatments in zebrafish hearts (Zhou et al.,
2011). Furthermore, chemical inhibition of BMP signaling does not
affect iSMCs in zebrafish (Table S2), indicating once again a
specific role for TGFβ proteins. However, more-detailed genetic
studies are needed to understand the precise receptors and ligands
involved in this process and to exclude the involvement of other
signaling molecules.
Despite being a mesodermal tissue, LPM has been described as a
polarized epithelium (before 30 hpf) by expression and apical
localization of aPKC (Horne-Badovinac et al., 2003). We now show
that markers of mesenchymalization (e.g. N-cadherin) are also
already present at this developmental stages, questioning the nature
of undifferentiated LPM as bona fide epithelium. Later on during
development, LPM/hand2+ cells migrate around the gut to give rise
to iSMC precursors (48 hpf) in a process that we found to be
dependent on Alk5/TGFβ signaling. We reasoned that an important
role for TGFβ/zeb1a could be to promote the acquisition of
migratory phenotype for LPM. In particular, LPM migration could
be driven by a TGFβ-induced partial EMT process. Indeed, unlike
canonical EMT, which transforms epithelial layers into individual
motile mesenchymal cells, LPM migrates as a cohesive layer of
mesenchymal cells. The LPM thus retains at the same time epithelial
features such as cell-cell contacts and a supracellular organization,
and mesenchymal features such as migration and the ability of ECM
remodeling (Yin et al., 2010).
Interestingly, we also found that the migration program in the
differentiating LPM could be switched off by miR-145, a
microRNA that has already been shown to modulate EMT acting
as a tumor suppressor gene in other contexts. In particular, being
able to directly bind the 3′ UTRs of oct4 and zeb2 transcripts, miR-
145 has been considered as a regulator of invasion and stem cell
properties in prostate and lung cancer (Hu et al., 2014; Ren et al.,
2014). Our data show that miR-145 regulates iSMC development
and differentiation in similar manner by regulating LPM migration
and proliferation and homeostasis via zeb1a and foxo1a repression,
respectively. miR-145 expression is controlled by TGFβ as master
regulator of migration, invasion and EMT, and that miR-145 in turn
represses several TGFβ downstream target genes. This interplay
establishes an autoregulatory negative-feedback loop that
spatiotemporally demarcates LPM migration. Other work showed
thatmiR-145 regulates, and is regulated by, TGFβ signaling in other
cell types (Long and Miano, 2011; Zhao et al., 2015), reinforcing
the existence of such a feedback loop. Nonetheless, we noticed that
miR-145 expression occurs later than initial TGFβ activation,
suggesting the existence of a regulatory mechanism that keeps miR-
145 transcriptionally silent until its action is needed. More-detailed
insights are required into the genetic and epigenetic mechanisms
of miR-145 transcriptional regulation in the smooth muscle field
and cancer. Besides its role in cancer progression, miR-145 has
been found as one of the most enriched miRNAs in vascular
smooth muscle cells (vSMCs), where miR-145 is required for
vSMC maturation and further regulation of their plasticity and
contractility (Albinsson and Swärd, 2013; Boettger et al., 2009;
Chivukula et al., 2014; Cordes et al., 2009; Elia et al., 2009; Xin
et al., 2009). Many miR-145 target genes have been shown to be
involved in these processes; yet, our newly found connection to
zeb1a and foxo1a in iSMCs also suggests that these two novel
players might be involved in the regulation of smooth muscle cell
plasticity.
By analyzing the direct targets of miR-145, we identified Foxo1a
as a potent and unforeseen player in intestinal smooth muscle
differentiation. Forkhead box O (FOXO) transcription factors are
involved in widespread regulation of the cell cycle, apoptosis and
metabolism (Eijkelenboom and Burgering, 2013). Support for a role
for Foxo1 in smooth muscle cell differentiation also arises from
work on mesodermal precursor cells derived from mouse Foxo1−/−
embryonic stem cells (ESCs) that fail to form vascular smooth
muscle cells (Park et al., 2009). In vitro ESC differentiation models
revealed that Foxo1 activity plays a key role in progenitor cell and
stem cell maintenance: Foxo1 is an essential component of the
cellular control mechanism that maintains pluripotency in human
embryonic stem cells (hESCs) through direct control of OCT4 and
SOX2 gene expression by occupation and activation of their
respective promoters (Zhang et al., 2011). In the same model
system, Xu and co-workers have reported that expression of miR-
145 is low in self-renewing hESCs but highly upregulated during
differentiation via direct binding and repression ofOCT4, SOX2 and
KLF4 (Xu et al., 2009). Here, we demonstrate that foxo1a
expression is enriched in the hand2+ zebrafish LPM and its
absence impairs LPM patterning and differentiation. Furthermore,
our data reveal that foxo1a overexpression maintains the
undifferentiated/embryonic state of LPM as hand2-positive tissue.
We propose a model where miR-145 expression is required to drive
mesoderm lineage-restricted differentiation into SMCs by
repressing expression of Foxo1. A role for foxo1a in endoderm-
derived tissues is conceivable during development, although this
function must be unrelated to its regulation bymiRNA-145. Overall,
we report here that Foxo1 is a direct target ofmiR-145, which in turn
supports the previously unforeseen link between miR145 and
stemness via Foxo1.
In summary, we have genetically established that the iSMCs are a
cell fate of the LPM, and we have uncovered a new molecular
pathway that promotes the coordinated cellular events that drive the
LPM towards iSMC differentiation during vertebrate development
(Fig. 7). In particular, we have found that miR-145, zeb1a and
foxo1a are interconnected key players during iSMC differentiation
in zebrafish. Our findings propose a new regulatory pathway
through which TGFβ/Alk5 input commits the hand2-positive LPM
stripes towards forming iSMC precursors by tuning a tissue-specific
mesenchymalization process via zeb1a and miR-145 expression. In
particular, miR-145 provides Alk5 signaling with a broadly acting
tool to influence the downstream post-transcriptional dynamics of
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mesenchymalization. In parallel, we have identified foxo1a as an
LPM-expressed gene involved in iSMC differentiation that is also
regulated by the Alk5 and miR-145 signaling. Alteration in these
developmental processes can result in genetic disorders, such as
visceral myopathy. Our work provides a new molecular framework
from which to analyze these molecular players for their prognostic
and therapeutic potential in human gastrointestinal genetic diseases
and cancers arising from dedifferentiated iSMCs (Spoelstra et al.,
2006; Wangler et al., 2014; Yamamoto and Oda, 2015).
MATERIALS AND METHODS
Zebrafish lines
Zebrafish were handled according to established protocols and
maintained under standard laboratory conditions. The Tg(hsp70l:Hsa.
TGFBR1_T204D-HA,cryaa:Cerulean)fb6Tg [referred to as Tg(hsp70:
caALK5)], TgBAC(hand2:EGFP)pd24, Tg(Xla.Eef1a1:GFP)s854, TgBAC
(cldn15la-GFP)pd1034, Tg(-6.4drl:creERT2) and ubi:Switch lines have
been described previously (Mosimann et al., 2015; Mosimann and Zon,
2011; Ober et al., 2006; Rohr et al., 2006; Yin et al., 2010; Zhou et al., 2011;
Alvers et al., 2014). The generation of the Tg(acta2:mCherry)uto5 and
Tg(tagln:EGFP)uto37 lines is described below. Following fertilization,
embryos were collected and grown in the presence of 0.003% 1-phenyl-2-
thiourea (PTU, Sigma-Aldrich) to prevent the formation of melanin
pigment.
Promoter analyses and generation of the zebrafish transgenic
lines
We analyzed the list of transcription factors represented by JASPAR
positional weight matrices (Table S1). For acta2, the AVID alignment tool
from VISTA has been used to directly align the region spanning from 2 kb
upstream of the TSS to the end of the first intron of ACTA2 in zebrafish,
human and mouse. We located the predicted binding sites in the D. rerio
genome for the above-mentioned transcription factors using a log-likelihood
ratio score, with the background nucleotide frequencies computed over the
entire intergenic fraction of theD. rerio genome. The cutoff score was set to
66% of the best possible score for the PWMor an absolute score greater than
9. The Tol2-based acta2:mCherry and tagln:EGFP-CAAX constructs were
assembled using the Tol2 Kit and a three-fragment gateway recombination
cloning strategy (Kwan et al., 2007). For 5′ entry cloning, ∼350 bp of the
acta2 promoter was amplified from the genomic DNA of wild-type
zebrafish by PCR with the following primers containing appropriate attB4
and attB1r sites: 5′-GGGGACAACTTTGTATAGAAAAGTTGGCCATT-
CCTTCTCAGGTGTGG-3′ and 5′-GGGGACTGCTTTTTTGTACAAAC-
TTGGGCACTTACCCTGACAGTGC-3′, respectively. The PCR product
was then cloned into pDONRP4-P1R by BP reaction to obtain p5E-acta2.
For middle entry cloning, the zebrafish acta2 first intron was amplified with
the following primers containing appropriate attB1 and attB2 sites: 5′-G-
GGGACAAGTTTGTACAAAAAAGCAGGCTACCTAGCTTCTCTCA-
CCTCC-3′ and 5′-GGGGACCACTTTGTACAAGAAAGCTGGGTTT-
TCAGCTCGGATATCCTTTCTTACTCC-3′, respectively, and cloned into
pDONR221 by BP reaction. The 3′ entry clone was p3E-mCherrypA. Entry
vectors were assembled in the pDestTol2pA2 vector by LR reaction to create
the pDestTol2-acta2-mCherry-pA vector. For the tagln gene, ClustalW
alignment was used to align the region spanning 2 kb upstream of the TSS of
tagln in four different fish species (zebrafish, Tetraodon, stickleback and
medaka). This multiple alignment was used as input to calculate the log-
likelihood ratio score of the transcription factor binding represented by
JASPAR positional weight matrices. The score cutoff was set to 50% of the
best possible score for the PWM. For generation of the tagln:CAAX-EGFP
construct, the 2 kb tagln promoter was amplified from the genomic DNA of
wild-type zebrafish with the following primers containing appropriate attB4
and attB1 sites: 5′-GGGGACAACTTTGTATAGAAAAGTTGAGACGA-
CAGAATAGAGAGGGCGGTGT-3′ and 5′-GGGGACTGCTTTTTTGT-
ACAAACTTGCAGCAGCTTTATGTTCAGCACGG-3′, respectively. The
PCR product was then cloned into pDONRP4-P1R by BP reaction to obtain
p5E-tagln. pME-EGFP-CAAX was used as a middle element, and the 3′
element was p3E-polyA. Entry vectors were assembled with the vector
Fig. 7. Schematic model of themolecular and
cellular events of iSMC development and
differentiation in zebrafish. (A) By 24 hpf, the
remaining undifferentiated LPM (green) has
migrated towards the endodermal rod (pink) at
the midline. By 48 hpf, the LPM has migrated
around the endoderm, which involves TGFβ/
Zeb1a signaling. foxo1awas also required in the
LPM to promote LPM differentiation. By 72 hpf,
the LPM cells began to express early smooth
muscle markers, such as Tagln and Acta2, and
became immature iSMCs. p, pronephros; PCV,
posterior cardinal vein; s, somite; y, yolk.
(B) During iSMC commitment, miR-145
expression was activated by TGFβ signaling.
miR-145 was required to switch off the Zeb1a-
mediated mesenchymalization genetic program
and generate a negative-feedback loop of TGFβ
signaling. miR-145 was also required to
downregulate foxo1a, stop the proliferation and
allow differentiation of iSMCs.
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pDestTol2pA2 by LR reaction to create the vector pDestTol2-tagln-
EGFPCAAX-pA. The vectors were mixed with mRNA for Tol2
transposase and microinjected into one-cell stage wild-type embryos.
Injected embryos were raised to adulthood, and founders were screened for
red fluorescence in SMCs. The transgenic fish line names Tg(acta2:
mCherry)uto5 and Tg(tagln:CAAX-EGFP)uto37 were approved by the
Zebrafish Nomenclature Committee of the ZFIN (http://zfin.org).
Immunofluorescence staining
Immunofluorescence was performed as previously described (Santoro
et al., 2009). Briefly, embryos were fixed in 4% paraformaldehyde at 4°C
overnight and washed three times in PBS. For immunofluorescence on
sections, embryos were embedded in 4% low-melting agarose (Sigma-
Aldrich). Sections (250 μm) were obtained using a vibratome (VT1000 S,
Leica), permeabilized with 1% BSA, 1% DMSO and 0.3% Triton X-100
in PBS for 30 min at room temperature, and then incubated with primary
antibody at 4°C overnight. After washing in PBS-T (0.1% Triton X-100
and 1% BSA in PBS), the sections were incubated with secondary
antibodies (Alexa Fluor, Life Technologies) and Hoechst 33342 (Life
Technologies) for 4 h at room temperature. The sections were washed in
PBS-T, followed by PBS, then mounted on slides with Vectashield
(Vector Labs). For whole-mount immunofluorescence, the fixed embryos
were permeabilized in 1% DMSO and 1% Triton X-100 for 30 min at
room temperature and then blocked in 4% BSA and 0.3% Triton X-100
in PBS for 4 h at room temperature. Embryos were incubated with the
primary antibody at 4°C overnight, washed and incubated with secondary
antibodies for 2 h at room temperature. After the washes, the embryos
were embedded in 4% low-melting agarose and sectioned at the
vibratome. The sections were mounted on slides with Vectashield. A
polyclonal anti-transgelin antibody was produced using the C-terminal
sequence (Santoro et al., 2009). For neuronal staining, the monoclonal
antibody anti-Hu was used (1:50; mAB 16A11, Molecular Probes). For
LPM staining, antibody anti-N-cadherin (1:200, Genetex) and aPKC
(1:200, SantaCruz) were used. For actin staining, the sections were
permeabilized and incubated with fluorescein isothiocyanate-labeled
(1:1000 for 2 h at room temperature; Sigma-Aldrich) or
tetramethylrhodamine B isothiocyanate-labeled (1:500 for 2 h at room
temperature; Sigma-Aldrich) phalloidin after the washes.
Confocal and stereo microscopy analyses
Images were acquired with a TCSII SP5X confocal microscope, a MZ16 FA
stereomicroscope equipped with a DCF300FY camera (Leica) or a AZ100
stereomicroscope equipped with an AxioCam MRm camera (Zeiss). The
LAS AF and Zen software suites were used for analysis and image
processing. Whole-embryo confocal images were acquired using the tile
scan and automated mosaic merge functions of Leica LAS AF software.
Digital micrograph images were contrast balanced, color matched, cropped
and rotated using Photoshop 7 (Adobe).
Genetic lineage-tracing experiments
Cell-tracing experiments were performed essentially as previously described
(Felker et al., 2016; Mosimann and Zon, 2011). Briefly, embryos from
Tg(-6.4drl:creERT2) (Mosimann et al., 2015) and ubi:Switch line intercross
were treated with fresh 10 µM 4-OH tamoxifen (H7904, Sigma-Aldrich) in
DMSO at the one-somite stage, with subsequent thorough washing of the
embryos in untreated E3 medium at 24 hpf. At the indicated time points,
embryos were fixed and processed for confocal analyses.
Whole-mount in situ hybridization
The in situ hybridization probes were designed with an oligonucleotide-
based method. An oligonucleotide pair (including T7 promoter) was used to
amplify target region (CDS or 3′UTR) from zebrafish cDNA, followed by
in vitro transcription including DIG-labeled NTPs (Roche). Afterwards,
RNAwas precipitated with lithium chloride, washed with 75% ethanol and
dissolved in DEPCwater. RNA quality was checked on aMOPS gel. For the
zeb1a in situ hybridization probe, the following primers were used: GAG-
GAGTGCGTCAGTGATGAGG and TAATACGACTCACTATAGGCA-
GGTGCTCCTTCAGGTGATGC (rev with T7). For the foxo1a in situ
hybridization probe the following primers were used: GTGGAGCTAAA-
TTGCAAGGACG and TAATACGACTCACTATAGGCGTGTAAACTC-
TCTGTACACCG (rev with T7).
Flow-activated cell sorter experiments
Embryos were disaggregated into single cells as previously described
(Mugoni et al., 2013). A FACSCalibur flow cytometer (BD Biosciences)
and the Cell Quest software were used to measure the percentage of
fluorescent cells. A FACS ARIA III sorter (BD Biosciences) was used to
isolate single cells for subsequent RNA extraction.
Chemical treatments on zebrafish embryos
Chemicals for zebrafish treatments were dissolved in DMSO. Zebrafish
embryos were treated with the following drugs: SB431548 (50 μM; Sigma-
Aldrich); AS1842856 (100 nM; Calbiochem); LY364947 (50 μM; Sigma-
Aldrich); purmorphamine (10-100 μM; Calbiochem); cyclopamine (50 μM;
Calbiochem); dorsomorphin (10-100 μM; Sigma-Aldrich); LDN193189
(250 nM-1 μM; Sigma-Aldrich); GM6001 (50-200 μM; Merck Millipore);
SU1498 (5-100 μM; Calbiochem); SU5416 (10-100 μM; Sigma-Aldrich);
L-NAME (100-500 μM; Sigma-Aldrich); SNAP (100-500 μM; Sigma-
Aldrich); and PDGFR tyrosine kinase inhibitor V 521234 (1-100 μM;
Calbiochem). The treatments were administered from 20 to 72 hpf.
Chemicals were refreshed daily.
Gene knockdown experiments
Gene knockdown experiments were performed by microinjecting
morpholinos (Table S4) into zebrafish embryos at the one-cell stage.
Morpholinos were synthetized from GeneTools and dissolved in nuclease-
free water. The primers for testing the efficacy of the zeb1amorpholinowere
designed using the zebrafish zeb1a sequence (GenBank accession number:
XM_001344071.6) and are as follows: zeb1a_ex2_Fw, 5′-GCGACCTC-
AGATTCAGATG-3′; zeb1a_ex3_Rv, 5′-TGACCCTTATTTCTCGTATT-
AAAG-3′; and zeb1a_in2_Rv, 5′-CTATGTGATTGTGCCTGATG-3′. The
primers for testing knockdown by the foxo1amorpholino were designed for
zebrafish foxo1a (GenBank accession number NM_001077257.2) and are
as follows: foxo1a_ex2_Fw, 5′-GGGAAAAGTGGAAAGTCTCC-3′; foxo1a_
ex3_Rv, 5′-TGTGTGGGTGAGAAAGAGTG-3′; and foxo1a_in2 _Rv, 5′-
TGAATGTGGCCTGAATGAG-3′. As a control, β-actin was detected with the
following primers: β-actin_Fw, 5′-GTATCCACGAGACCACCTTCA-3′; and
β-actin_Rv, 5′-GAGGAGGGCAAAGTGGTAAAC-3′.
Heat shock experiments
Heat-shock experiments on Tg(hsp70l:Hsa.TGFBR1_T204D-HA,cryaa:
Cerulean)fb6Tg were performed essentially as previously described (Zhou
et al., 2011) by administering a 37°C heat shock for 1 h to transgenic and
clutch mate controls. For miR-145 analyses, embryos were heat shocked
at 48 hpf and 72 hpf, and RNA from the trunk was extracted after 6 and
24 h, respectively. For coding gene analyses, embryos were heat shocked
at 48 hpf and RNA from trunk was extracted after 24 h.
Analysis of mammalian gene expression profiling
Data from a previous study (Sartor et al., 2010) were analyzed to obtain a list
of genes differentially expressed between A459 cells after 72 h of TGFβ
induction and untreated cells. Using limma (Smyth, 2005) and a false
discovery rate (FDR) of 0.01, 1725 upregulated probes and 1444
downregulated probes corresponding to 1010 and 981 unique genes,
respectively, were obtained. Similarly, data from Li et al. (2007) were
analyzed to obtain a list of genes differentially expressed between the
mesenchymal and epithelial fractions of mouse intestine. Using limma and an
FDR cutoff of 0.01, we found that 9272 probes were upregulated in the
mesenchymal fraction and 3595 were downregulated, corresponding to 5380
and 2384 unique genes, respectively.
miR-145 target analysis
The miR-145 target predictions were based on the latest TargetScan release
(6.2). In particular, we used the mouse orthologs of the human annotations
for mouse predictions and the annotated zebrafish UTRs for zebrafish
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predictions (Ulitsky et al., 2012). Gene overlaps and comparisons between
different species were based on the Homologene (build66) orthology
database.
Peristalsis analysis on zebrafish embryos
Embryos were anesthetized with 0.04 mg/ml tricaine (Sigma-Aldrich),
mounted in 3% methyl cellulose (Sigma-Aldrich), and allowed to adapt for
5 min before recording. Each embryo was recorded for 1 min with an MZ16
FA stereomicroscope equipped with a DCF300FY camera (Leica). The
frequency and amplitude of peristaltic movements were compared between
controls and injected embryos. Forty embryos per group were analyzed in
two independent experiments.
Luciferase assay experiments
Luciferase reporter vectors containing the 3′ UTR of the indicated miR-145
target genes were generated by PCR amplification of the 3′ UTR from
zebrafish genomic DNA and subsequent cloning into the Firefly luciferase
reporter pMIR-REPORT vector (Ambion). When indicated, the 3′ UTRs
were mutagenized or deleted at the miR-145 recognition site using the
QuikChange Site-Directed Mutagenesis kit (Stratagene), according to the
manufacturer’s instructions with the primers listed below. A total of 5×104
HEK293 cells was co-transfected with 50 ng of the pMIR-REPORT
(Ambion) Firefly luciferase constructs containing the 3′ UTRs of the
indicated miR-145 potential target genes and 20 ng of pRL-TK Renilla
luciferase normalization control (Promega) using Lipofectamine 2000
(Invitrogen Life Technologies). Lysates were collected 48 h after
transfection, and Firefly and Renilla luciferase activities were measured
with a Dual-Luciferase Reporter System (Promega). The foxo1a 3′ UTR
was amplified with the following primers: foxo1a_3′UTR_Fw, 5′-
GTGGAGCTAAATTGCAAGGAC-3′; and foxo1a_3′UTR_Rv, 5′-
TTAACCACGCCCCTCTTATG-3′. miR-145 binding sites were mutated
in foxo1a 3′ UTR using the following primers: foxo1a_Mut1_Fw, 5′-GG-
GAAGAAGCCCGGGTGAGCGGGAATCGCTG-3′; foxo1a_Mut1_Rv,
5′-CAGCGATTCCCGCTCACCCGGGCTTCTTCCC-3′; foxo1a_Mut2_
Fw, 5′-GTAAATCGGAGAGATCCCGGGTTCGACGTTTTTAC-3′; and
foxo1a_Mut2_Rv, 5′-GTAAAAACGTCGAACCCGGGATCTCTCCGA-
TTTAC-3′.
The zeb1a 3′ UTR was amplified with the following primers: zeb1a_3′
UTR_Fw, 5′-CTTACAGGGGTGATTCTCATG-3′; and zeb1a_3′UTR_Rv,
5′-AACGACTGACACGTTACACAC-3′. miR-145 binding sites were
deleted in the zeb1a 3′ UTR using the following primers:
zeb1a_Mut1_Fw, 5′-CAAATTTATGCGTATTCCCGGGTGCTGCACG-
ATATTGG-3′; zeb1a_Mut1_Rv, 5′-CCAATATCGTGCAGCACCCGGG-
AATACGCATAAATTTG-3′; zeb1a_Mut2_Fw, 5′-CTTTTCACAATCT-
TCAGTGTTTGTCATTTGATCCCGGGAGAGTTTCTCACGTGTTGTT-
TGATT-3′; and zeb1a_Mut2_Rv, 5′-AATCAAACAACACGTGAGAAA-
CTCTCCCGGGATCAAATGACAAACACTGAAGATTGTGAAAAG-3′.
Quantitative real-time PCR analyses
RNA was isolated with TRIzol reagent (Invitrogen Life Technologies), and
cDNA was made with a RT High Capacity kit (Applied Biosystems),
according to the manufacturer’s protocol. qRT-PCR was performed with an
ABI 7900HT Fast Real-Time PCR System (Applied Biosystems) using
Platinum qPCR SuperMix-UDG with ROX (Invitrogen Life Technologies).
The following genes were analyzed: acta2 (NM_212620.1); tagln
(NM_001045467.1); myh11 (NM_001024448.1); foxa3 (NM_131299.1);
foxo1a (NM_001077257.2); zeb1a (XM_001344071.6); hand2
(NM_131626.2); E-cadherin (NM_131820.1); N-cadherin (NM_131081.2);
occludin A (NM_212832.2); twist1a (NM_130984.2); twist1b
(NM_001017820.1); snai1a (NM_131066.1); snai1b (NM_130989.3); and
snai2 (NM_001008581.1). The β-actin gene (actb) was included as a control
housekeeping gene (NM_131031.1 and NM_181601.4). Specific primers
were designed with the dedicated UPL on-line tool (Roche) and are provided
in Table S5. Data were analyzed using the ΔΔCt method with ABI software,
version 2.1 (Applied Biosystems). For microRNA analyses, RNA was
extracted using the TRIzol reagent (Invitrogen Life Technologies). qRT-PCR
for microRNA detection was performed with the indicated TaqMan
microRNA assays (Applied Biosystems) on 10 ng of total RNA according
to the manufacturer’s instructions. qRT-PCR was conducted using gene-
specific primers on a 7900HT Fast Real-Time PCR System (Applied
Biosystems). Quantitative normalization was performed for the expression of
the RNU6 small nucleolar RNA.Data analysis was performed using the ΔΔCt
method with the ABI software, version 2.1 (Applied Biosystems).
Northern blot analyses
Total RNA (20 μg) isolated as above was resolved by 12.5% (w/v) TBE-
urea-polyacrylamide gel electrophoresis and transferred to a Hybond N+
membrane (GE Healthcare Life Sciences). The filter was hybridized
overnight at 45°C with a specific miR-145 digoxigenin-labeled LNA
detection probe (Exiqon), washed and visualized with a specific DIG
antibody (1:10,000) using the DIG Nucleic Acid Detection kit (all from
Roche). The filter was then stripped and re-probed overnight at 45°C using a
specific U6 digoxigenin-labeled LNA detection probe (Exiqon).
hand2-positive cell proliferation analyses
Phosphohistone H3 (Ser10, Cell Signaling) immunofluorescence was used
to evaluate cell proliferation. The staining was performed on cross-sections
of the gut of Tg(hand2:EGFP)pd24 at 48 hpf. Ph3/hand2 double-positive
cells and hand2 single-positive cells were counted in a minimum of three
distinct sections per embryo in eight individual animals. The ratios are
represented normalized to controls.
foxo1a overexpression experiments
The complete zebrafish foxo1a CDS was amplified by PCR from cDNA
using the primers: foxo1a_Fw, 5′-GTACCATGGCTGACGCAG-3′ and
foxo1a_Rv, 5′-CTACCCAGACACCCAGCTG-3′. Purified PCR product
was cloned in pCS2+ vector. foxo1a mRNA was synthesized using the
mMessage Machine kit (Ambion) following the manufacturer’s
instructions. Wild-type embryos were injected at the one-cell stage with
100 pg of foxo1a mRNA. We also included a control mRNA encoding the
fluorescent protein mCherry (100 pg) in each injection.
Statistical analyses
All experiments were performed at least three independent times for each
condition, and the error bars represent the mean±s.d. of the mean unless
otherwise stated. Statistical significance was evaluated by Student’s test or
one-way ANOVA-Dunnett’s post-hoc test as appropriate, and significance
is reported as *P<0.05, **P<0.01, ***P<0.001 and ****P<0.0001.
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